Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report. | NPJ Genom Med | 2025 | 40368914 | PubTator, text mining | PubMed |
| Pilocytic astrocytoma with BARD1 mutation: oncogenic pathways via DNA damage repair mechanism and MAPK/BRAF. | Pathology | 2025 | 40318960 | PubTator, text mining | PubMed |
| A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. | J Exp Clin Cancer Res | 2025 | 40275348 | PubTator, text mining | PubMed |
| Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation. | JAMA Netw Open | 2025 | 40249615 | PubTator, text mining | PubMed |
| Next-Generation Sequencing in Oncology-A Guiding Compass for Targeted Therapy and Emerging Applications. | Int J Mol Sci | 2025 | 40243903 | PubTator, text mining | PubMed |
| Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult Counterparts. | Mod Pathol | 2025 | 40222653 | PubTator, text mining | PubMed |
| Identification of RING E3 pseudoligases in the TRIM protein family. | Nat Commun | 2025 | 40216791 | PubTator, text mining | PubMed |
| Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer. | BMC Cancer | 2025 | 40205351 | PubTator, text mining | PubMed |
| The Breast Tumor Immune Microenvironment of DNA Double-Strand Break Repair Pathogenic Variant Carriers Is Enriched with Tumor-Associated Macrophages. | Cancer Epidemiol Biomarkers Prev | 2025 | 40172573 | PubTator, text mining | PubMed |
| The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivo. | BMC Cancer | 2025 | 40119293 | PubTator, text mining | PubMed |
| Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinoma. | Neoplasia | 2025 | 40096771 | PubTator, text mining | PubMed |
| Improving neuroblastoma risk prediction through a polygenic risk score derived from genome-wide association study-identified loci. | Chin J Cancer Res | 2025 | 40078563 | PubTator, text mining | PubMed |
| Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing. | ESMO Open | 2025 | 40068381 | PubTator, text mining | PubMed |
| Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men. | Nat Commun | 2025 | 40064858 | PubTator, text mining | PubMed |
| SART3 promotes homologous recombination repair by stimulating DNA-RNA hybrids removal and DNA end resection. | Nat Commun | 2025 | 40050279 | PubTator, text mining | PubMed |
| Reclassification of variants of uncertain significance by race, ethnicity, and ancestry for patients at risk for breast cancer. | Front Oncol | 2025 | 40040729 | PubTator, text mining | PubMed |
| Genomic features of bladder neuroendocrine carcinoma with composite histology. | Histol Histopathol | 2025 | 40013766 | PubTator, text mining | PubMed |
| Germline Mutations in Renal Neoplasms and Their Clinicopathological Correlations. | Int J Surg Pathol | 2025 | 40012254 | PubTator, text mining | PubMed |
| Causative Genes of Homologous Recombination Deficiency (HRD)-Related Breast Cancer and Specific Strategies at Present. | Curr Oncol | 2025 | 39996890 | PubTator, text mining | PubMed |
| The Emerging Role of the Histone H2AK13/15 Ubiquitination: Mechanisms of Writing, Reading, and Erasing in DNA Damage Repair and Disease. | Cells | 2025 | 39996778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=9